-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on 10x Genomics, Raises Price Target to $24

Benzinga·04/07/2026 18:11:37
Listen to the news
Citigroup analyst Patrick Donnelly maintains 10x Genomics (NASDAQ:TXG) with a Neutral and raises the price target from $18 to $24.